Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.76 USD | -4.14% | -4.18% | -16.12% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 407M | Capitalization | 1.17B |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | 30M | EV / Sales 2024 * | 2.89 x |
Net cash position 2024 * | 256M | Net cash position 2025 * | 301M | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 * |
-18.6
x | P/E ratio 2025 * |
84.8
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.27% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | -4.14% | ||
1 week | -4.18% | ||
Current month | -1.39% | ||
1 month | -3.39% | ||
3 months | -11.51% | ||
6 months | -13.46% | ||
Current year | -16.12% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 24.76 | -4.14% | 429,935 |
24-05-09 | 25.83 | +3.15% | 631,766 |
24-05-08 | 25.04 | -3.36% | 357,020 |
24-05-07 | 25.91 | -1.82% | 271,526 |
24-05-06 | 26.39 | +2.13% | 327,946 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.12% | 1.17B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- MIRM Stock